PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
18.54%
Revenue growth exceeding 1.5x CRWD's 5.94%. David Dodd would verify if faster growth reflects superior business model.
No Data
No Data available this quarter, please select a different quarter.
18.54%
Gross profit growth exceeding 1.5x CRWD's 5.45%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
18.54%
EBITDA growth while CRWD declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
18.54%
Operating income growth exceeding 1.5x CRWD's 9.37%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
-18.54%
Other expenses reduction while CRWD shows 18.80% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.10%
Share count reduction while CRWD shows 0.59% change. Joel Greenblatt would examine strategy.
-0.10%
Diluted share reduction while CRWD shows 0.59% change. Joel Greenblatt would examine strategy.